Community Hospital

29125 APPLICATION OF SHORT ARM SPLINT (FOREARM TO HAND); STA

29130 ed proc application of finger splint static

36000 ed proc introduction of needle or intracathe

3D RENDERING WITH INTERPRETATION AND REPORTING OF COMPUTED TOMOGRAPHY, MAGNETIC RESONANCE IMAGING, ULTRASOUND, OR OTHER TOMOGRAPHIC MODALITY WITH IMAGE POSTPROCESSING UNDER CONCURRENT SUPERVISION; REQUIRING IMAGE POSTPROCESSING ON AN INDEPENDENT WORKSTATION

58160-0890-52 - influenza virus vaccine, inactivated preservative-free quadrivalent Sus [MEMO]

67938 ed proc remove fb eyelid- hospital

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITH IMAGING GUIDANCE

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITHOUT IMAGING GUIDANCE

ABL1 (ABL PROTO-ONCOGENE 1, NON-RECEPTOR TYROSINE KINASE) (EG, ACQUIRED IMATINIB TYROSINE KINASE INHIBITOR RESISTANCE), GENE ANALYSIS, VARIANTS IN THE KINASE DOMAIN

ACETAZOLAMIDE LESS THAN500MG 500MG 5MLSNIJ

ACETYLCHOLINE RECEPTOR (ACHR); BINDING ANTIBODY

ACETYLCHOLINE RECEPTOR (ACHR); BLOCKING ANTIBODY

ACETYLCHOLINE RECEPTOR (ACHR); MODULATING ANTIBODY

ACETYLCYSTEINE 200 MG/ML (20 %) INTRAVENOUS SOLUTION [35100]

ACTIN (SMOOTH MUSCLE) ANTIBODY (ASMA), EACH

ACUTE HEPATITIS PANEL THIS PANEL MUST INCLUDE THE FOLLOWING: HEPATITIS A ANTIBODY (HAAB), IGM ANTIBODY (86709) HEPATITIS B CORE ANTIBODY (HBCAB), IGM ANTIBODY (86705) HEPATITIS B SURFACE ANTIGEN (HBSAG) (87340) HEPATITIS C ANTIBODY (86803)

ACYCLOVIR SODIUM 50 MG/ML INTRAVENOUS SOLUTION [4235]

ADALIMUMAB 20MG 40MG 0.8ML SNIJ

ADALIMUMAB CONC & ABS (LCP 503890)

ADAMTS13 RCM KRHN 10IU 500IU IJKT

ADMINISTRATION OF HEPATITIS B VACCINE

ADMINISTRATION OF INFLUENZA VIRUS VACCINE

ADMINISTRATION OF PNEUMOCOCCAL VACCINE

ADRENOCORTICOTROPIC HORMONE (ACTH) LEVEL

AFP TETRA (LCP 017319)(ESTRIOL)

AFP TETRA (LCP 017319)(INHIBIN A)

ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION

ALLERGEN SPECIFIC IGE; QUALITATIVE, MULTIALLERGEN SCREEN (EG, DISK, SPONGE, CARD)

ALLERGEN SPECIFIC IGE; QUANTITATIVE OR SEMIQUANTITATIVE, CRUDE ALLERGEN EXTRACT, EACH

ALLERGEN SPECIFIC IGE; QUANTITATIVE OR SEMIQUANTITATIVE, RECOMBINANT OR PURIFIED COMPONENT, EACH

ALPHA-1-ANTITRYPSIN (PROTEIN) BLOOD TEST, PHENOTYPE

ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG (+/-)/20 ML IV SOLUTION [151394]

ALPHA-FETOPROTEIN (AFP); AFP-L3 FRACTION ISOFORM AND TOTAL AFP (INCLUDING RATIO)

ALTEPLASE 2 MG INTRA-CATHETER SOLUTION [19101]

AMIKACIN 100MG 1000MG 4ML SNIJ

AMINO ACIDS, 6 OR MORE AMINO ACIDS, QUANTITATIVE, EACH SPECIMEN

AMINOPHYLLINE 25 MG/ML INTRAVENOUS SOLUTION (WRAPPED) [4000723]

AMNIOCENTESIS; THERAPEUTIC AMNIOTIC FLUID REDUCTION (INCLUDES ULTRASOUND GUIDANCE)

AMPHO B LIPID 10MG 100MG 20ML IJ

AMPHOTERICIN B 50 MG SOLUTION FOR INJECTION

AMPICILLIN 500 MG SOLUTION FOR INJECTION [13513]

AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION [14372]

AMPUTATION OF TOE AT JOINT BETWEEN FOREFOOT AND TOES

AMPUTATION, FINGER OR THUMB, PRIMARY OR SECONDARY, ANY JOINT OR PHALANX, SINGLE, INCLUDING NEURECTOMIES; WITH DIRECT CLOSURE

AMPUTATION, FINGER OR THUMB, PRIMARY OR SECONDARY, ANY JOINT OR PHALANX, SINGLE, INCLUDING NEURECTOMIES; WITH LOCAL ADVANCEMENT FLAPS (V-Y, HOOD)

ANALYSIS FOR ANTIBODY (IGM) TO CYTOMEGALOVIRUS (CMV)

ANALYSIS FOR ANTIBODY BORRELIA BURGDORFERI (LYME DISEASE BACTERIA)

ANALYSIS FOR ANTIBODY TO CYTOMEGALOVIRUS (CMV)

ANALYSIS FOR ANTIBODY TO EHRLICHIA (BACTERIA TRANSMITTED BY TICKS)

ANALYSIS FOR ANTIBODY TO EPSTEIN-BARR VIRUS (MONONUCLEOSIS VIRUS), NUCLEAR ANTIGEN